Modivcare's Financial Update and Revised Guidance
Modivcare Inc. (Nasdaq: MODV) has recently shared a significant financial update. As a company that leverages technology in healthcare services, Modivcare is committed to providing integrated supportive care solutions aimed at improving health outcomes for its clients. Today, they addressed recent filings with the U.S. Securities and Exchange Commission (SEC) and announced a change in their financial outlook.
Recent SEC Filings
The Company has filed a Form S-3 shelf registration statement with the SEC, which gives them the flexibility to raise capital over the coming three years. Along with this filing, a Form 8-K was submitted, providing more details. While they have a solid framework in place for potential funding, Modivcare does not plan to issue equity at this time.
Tackling Contract Receivable Challenges
Modivcare is actively pursuing covenant relief from its revolving credit facility to address potential delays in collections. They have engaged in advanced discussions with their banking partners, and these conversations have been cooperative.
Details on Contract Receivables
There is a strong level of confidence in collecting the outstanding receivables from managed care organizations (MCOs) and state payors. However, Modivcare has encountered delays, with around $60 million outstanding from a total of $159.3 million in the NEMT segment as of the end of June. This challenge is mainly due to the effects of Medicaid redeterminations, which have led to a rise in the utilization of shared-risk contracts.
Modivcare expects to enter the upcoming year with better prepayment rates as the utilization patterns stabilize, which should help ease collection difficulties.
Revised Financial Guidance and Anticipated Growth
In response to changes in their operational strategy, Modivcare has lowered its 2024 Adjusted EBITDA guidance from a range of $185 to $195 million down to $170 to $180 million. This adjustment aligns with their pricing strategies aimed at nurturing and expanding critical customer relationships within the NEMT segment.
Furthermore, the Company is projecting an Adjusted EBITDA growth of over 10% for the year 2025, based on this revised outlook.
Understanding Non-GAAP Financial Measures
Alongside the report, Modivcare clarified the financial measures they outlined; both EBITDA and Adjusted EBITDA represent performance that goes beyond traditional GAAP accounting metrics. Business performance is measured based on net income before taking interest expenses, taxes, and depreciation into account.
About Modivcare: Improving Health Outcomes
Modivcare Inc. is recognized for its provision of a range of integrated supportive care solutions geared towards public and private payors. They address the social determinants of health by ensuring that members have access to crucial care services. This commitment supports health plans in managing risks while reducing costs and enhancing outcomes.
The Company specializes in non-emergency medical transportation (NEMT), personal care services (PCS), and remote patient monitoring solutions (RPM). Additionally, Modivcare has invested in CCHN Holdings, known for its comprehensive in-home health assessments, which reflects their innovative approach to delivering healthcare solutions.
Frequently Asked Questions
What is Modivcare's main focus?
Modivcare specializes in technology-enabled healthcare services, offering integrated supportive care solutions to enhance health outcomes.
Which financial measures does Modivcare use?
Modivcare employs both GAAP and non-GAAP measures, including EBITDA and Adjusted EBITDA, to capture performance effectively.
Did Modivcare change its financial guidance?
Yes, Modivcare has revised its 2024 Adjusted EBITDA guidance as part of their updated strategy to maintain customer relationships.
What challenges has Modivcare encountered with receivables?
Modivcare has faced delays in collecting receivables, primarily due to Medicaid redeterminations impacting shared-risk contracts.
What growth does Modivcare foresee for the future?
Modivcare expects to achieve over 10% growth in Adjusted EBITDA for 2025 based on their latest adjustments.
